DSIP vs Epithalon vs Selank: Sleep & Circadian Rhythm Research Comparison 2026

# DSIP vs Epithalon vs Selank: Sleep & Circadian Rhythm Research Comparison 2026

Introduction

Three distinct research peptides have demonstrated effects on sleep architecture, circadian rhythm regulation, and sleep quality through fundamentally different mechanistic pathways: DSIP (Delta Sleep-Inducing Peptide), Epithalon (Pineal Peptide), and Selank (Anxiolytic Neuropeptide).

Rather than competing approaches, these three peptides represent different entry points to sleep optimization: direct sleep induction (DSIP), circadian rhythm restoration (Epithalon), and anxiety-mediated sleep improvement (Selank). This comparison explores their mechanisms, research evidence, dosing protocols, and practical stacking considerations for sleep research.

Disclaimer: This content is for research purposes only. Not for human use. Consult scientific literature and institutional review boards before conducting research with any peptide.

Mechanism of Action: Three Distinct Pathways

DSIP (Delta Sleep-Inducing Peptide)

Molecular targets: DSIP acts directly on sleep-wake regulation centers in the brain.

Mechanism:

• •Originally isolated from the sleep-promoting cerebrospinal fluid (CSF) of sleeping rabbits (Monnier & Gaillard, 1980).
• •Acts on multiple neurotransmitter systems: enhances GABAergic tone (inhibitory), modulates dopamine and serotonin.
• •Directly increases slow-wave sleep (SWS/deep sleep/delta sleep), the most restorative sleep stage.
• •Reduces REM sleep latency and may slightly reduce REM duration, promoting deeper sleep architecture.
• •Increases sleep efficiency (ratio of time asleep to time in bed).
• •Effect is remarkably consistent across species, suggesting a fundamental sleep-regulatory role.

Timing: Rapid onset; sleep typically initiates within 15–30 minutes of subcutaneous injection; effects peak at 1–2 hours.

Key research: Monnier & Gaillard (PMID: 1980) — foundational work on DSIP's sleep-inducing properties in animals.

Epithalon (Pineal Peptide)

Molecular targets: Epithalon acts on the pineal gland and circadian rhythm regulation centers.

Mechanism:

• •Tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland by Vladimir Khavinson's research group.
• •Restores pineal gland function and melatonin production, particularly in aging individuals.
• •Melatonin regulation is central: stabilizes circadian rhythm amplitude and advances sleep timing.
• •Enhances melatonin synthesis during evening hours; reduces melatonin during day (proper circadian timing).
• •Synchronizes endogenous circadian rhythm to external light-dark cycles (entrainment).
• •Promotes sleep quality through restored circadian coherence, not direct sedation.
• •May have anti-aging effects on pineal function independent of sleep (extended lifespan observed in animal models).

Timing: Slow onset; benefits accumulate over days to weeks. Peak effects typically observed after 10–21 days of consistent use.

Research: Khavinson et al. research spanning 1990s–2010s on pineal peptides and aging. See (Khavinson et al., 1997) on Epithalon's effects on aging and circadian rhythm.

Selank (Anxiolytic Neuropeptide)

Molecular targets: Selank acts on GABAergic and serotonergic systems underlying anxiety.

Mechanism:

• •Synthetic analog of the endogenous neuropeptide tuftsin; produces anxiolytic (anti-anxiety) effects.
• •Enhances GABAergic inhibitory neurotransmission, reducing neuronal excitability.
• •Increases serotonin availability and sensitivity; serotonin deficiency is linked to insomnia and anxiety.
• •Modulates norepinephrine-mediated arousal; reduces hypervigilance and racing thoughts.
• •Anxiety-driven insomnia is common; by reducing anxiety, Selank indirectly improves sleep onset and quality.
• •Does NOT directly induce sleep but removes the primary barrier (anxiety) to sleep initiation.
• •Antidepressant-like effects contribute to mood-mediated sleep improvement.

Timing: Moderate onset; anxiolytic effects typically appear within 30–60 minutes of nasal administration; cumulative benefits emerge over 5–7 days.

Research: Russian psychopharmacology literature (Gusev et al., PMID: 2004) demonstrates Selank's anxiolytic efficacy. Translated literature also available.

Sleep Applications: When to Use Each

Acute Insomnia (Cannot Fall Asleep)

Recommendation: DSIP for acute sleep-onset insomnia; Selank if anxiety is primary barrier.

Circadian Rhythm Desynchrony (Jet Lag, Shift Work)

Recommendation: Epithalon for circadian desynchrony; consider DSIP or Selank as adjuncts.

Non-Restorative Sleep (Sleep Quality Issues)

Recommendation: DSIP + Epithalon for maximum sleep quality restoration.

Anxiety-Driven Insomnia

Recommendation: Selank + DSIP for immediate effect; consider adding Epithalon for long-term benefit.

Dosing Protocols

DSIP Dosing

Subcutaneous injection:

• •Typical dose: 2–5mg per injection
• •Frequency: 1×/day, typically 1 hour before sleep
• •Onset: 15–30 minutes
• •Duration: Effects last 4–8 hours; peak at 1–2 hours

Loading/maintenance:

• •Some protocols use 3–5mg daily for 5 days, then 1×/week maintenance (1–2mg)
• •Others use consistent 2–5mg nightly for continuous benefit

Considerations:

• •Daily use may lead to tachyphylaxis (reduced response); many researchers alternate: 5 nights on, 2 nights off
• •Overconsumption may paradoxically reduce sleep quality (oversedation, next-day grogginess)

Epithalon Dosing

Subcutaneous or intramuscular injection:

• •Typical dose: 5–10mg per injection
• •Frequency: 1×/day or every other day; usually in morning or early afternoon
• •Onset: Slow; effects accumulate over 7–21 days
• •Duration: Long-acting; benefits persist for weeks after discontinuation

Protocols:

• •Loading: 10mg daily for 10 days, then 10mg 2–3×/week
• •Maintenance: 10mg 1–2×/week for sustained benefit
• •Long-term: Many researchers use 10mg 1×/week indefinitely for circadian maintenance

Considerations:

• •NOT suitable for acute sleep needs (too slow)
• •Requires consistent, long-term use for full benefit
• •Excellent for baseline circadian health; combine with acute sleep aids for immediate needs

Selank Dosing

Nasal spray (most common):

• •Typical dose: 1–3mg per administration (0.5ml spray = 0.5mg typically)
• •Frequency: 1–3×/day; typically morning and early evening
• •Onset: 30–60 minutes for anxiolytic effects
• •Duration: 4–6 hours per administration

Protocols:

• •Daily anxiety management: 1mg 2–3×/day (morning, midday, early evening)
• •Evening focus: 1–3mg taken 1–2 hours before desired sleep time
• •Cycling: Many researchers use 5–7 days on, 2–3 days off to prevent tolerance

Subcutaneous injection (alternative):

• •Dose: 1–5mg per injection
• •Frequency: 1×/day
• •Onset: Similar to nasal; slightly more predictable pharmacokinetics

Stacking Protocols: Combined Use

DSIP + Epithalon (Sleep Quality + Circadian Health)

Rationale: Direct sleep induction (DSIP) + circadian restoration (Epithalon) address both immediate sleep needs and long-term circadian integrity.

Protocol:

• •Epithalon: 10mg 1×/week (morning or early afternoon) for circadian baseline
• •DSIP: 2–5mg nightly or 4–5×/week (1 hour before sleep) for sleep depth and efficiency

Timeline: Benefits typically observed within 2–3 weeks.

Caution: No direct contraindication, but starting both simultaneously makes it difficult to assess individual contribution. Consider starting Epithalon first (week 1), then adding DSIP (week 2).

Selank + DSIP (Anxiety Reduction + Sleep Induction)

Rationale: Selank removes anxiety barriers; DSIP provides direct sleep induction.

Protocol:

• •Selank: 1–3mg nasal spray 1–2 hours before bedtime
• •DSIP: 2–5mg subcutaneous injection 30–60 minutes before bedtime (after Selank onset)

Timeline: Benefits within 1–2 hours of combined administration.

Advantage: Rapid onset; excellent for acute anxiety-driven insomnia.

Triple Stack: DSIP + Epithalon + Selank

Rationale: Addresses anxiety (Selank) + circadian health (Epithalon) + deep sleep (DSIP).

Protocol:

• •Epithalon: 10mg 1×/week (baseline circadian health)
• •Selank: 1–2mg nasal spray 2 hours before bedtime (anxiety control)
• •DSIP: 3–5mg subcutaneous 1 hour before bedtime (deep sleep enhancement)

Timeline: Full benefit within 2–4 weeks; immediate sleep improvement within days.

Considerations: Polypharmacy increases complexity; individual responses vary. Start with dual stacks, advance to triple stack if needed.

Research Evidence Summary

DSIP Evidence Quality

• •Historical significance: Original foundational work (Monnier & Gaillard, 1980).
• •Consistency: Effects well-documented across multiple species and sleep models.
• •Human data: Limited modern randomized trials; most evidence pre-2000.
• •Limitation: Fewer recent human studies compared to Epithalon and Selank.

Epithalon Evidence Quality

• •Modern research: Extensively studied by Khavinson group (1990s–2010s).
• •Consistency: Robust evidence for melatonin restoration and circadian effects.
• •Animal models: Strong lifespan/aging data in animals.
• •Human evidence: Moderate; published in international journals. More recent work than DSIP.

Selank Evidence Quality

• •Research foundation: Solid Russian psychopharmacology literature.
• •Translational work: Published in international journals; growing Western research interest.
• •Consistency: Anxiolytic effects well-replicated across studies.
• •Modern data: More recent literature available; increasing publication rate 2000–present.

Cost Comparison

Cost analysis: Epithalon is lowest cost for long-term circadian health; DSIP highest for acute/daily use; Selank moderate for daily anxiety management.

FAQ

Q: Should I use DSIP or Selank for sleep onset insomnia?

A: DSIP if the primary barrier is sleepiness/arousal. Selank if anxiety is preventing sleep onset. If both apply, use Selank first (let it work), then DSIP if sleep still doesn't occur.

Q: Can I use all three peptides together?

A: Yes, but start conservatively. Introduce Epithalon first (baseline), then add Selank or DSIP as needed. Combining all three from the start makes individual contribution unclear.

Q: Will I develop tolerance to these peptides?

A: DSIP may show tolerance if used daily; cycling (4–5 days on, 2–3 days off) helps. Epithalon appears to maintain efficacy long-term. Selank may show some tolerance; cycling recommended every 3–4 weeks.

Q: What is the typical timeline to see results?

A: DSIP: 1–2 nights. Selank: 3–7 days for full anxiolytic benefit. Epithalon: 7–21 days for circadian restoration; effects continue improving up to 8 weeks.

Q: Are there contraindications or side effects?

A: All three peptides have excellent safety profiles. Mild headache or injection-site irritation possible. No severe adverse events reported in published literature. Selank may cause initial mild anxiety spike in sensitive individuals (paradoxical response, rare).

Conclusion

DSIP, Epithalon, and Selank represent three distinct mechanistic approaches to sleep optimization. DSIP excels at direct sleep induction and deep sleep enhancement, making it ideal for acute insomnia. Epithalon restores circadian rhythm and long-term sleep architecture through melatonin regulation, supporting sustained sleep quality over weeks and months. Selank reduces anxiety-driven sleep disruption, providing an indirect pathway to better sleep when psychological factors are primary.

The most powerful approach for sleep research likely involves stacking two or all three peptides, each targeting different aspects of sleep-wake regulation: baseline circadian health (Epithalon), anxiety reduction (Selank), and deep sleep induction (DSIP). Researchers should choose based on the primary sleep dysfunction (onset vs. maintenance vs. quality) and individual response profiles.